EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19

EMA

16 December 2021 - Rolling review starts in parallel

EMA’s CHMP has issued advice on the use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19. 

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Europe , COVID-19